Synbiotic launches CBD without hemp on the market

The start-up extracts the cannabinoids from hops, among other things. This should allow the CBD products to be sold even in countries that ban hemp.

Smoking pot without hemp - Synbiotic has announced the launch of a CBD product that does not require hemp at all. "CBDplus" is also supposed to work many times more effectively, promises the start-up from Munich. CBD - not to be confused with the intoxicating and banned THC - is extracted from other cannabinoid and terpene-containing plants such as hops. "Preparations for the product launch are nearing completion," says Lars Müller, CEO of Synbiotic. "This makes us the first industry company worldwide to offer a real alternative to conventional CBD extracts." This means that CBD can also be sold in countries that previously banned hemp products or made it difficult to sell them, for example in China, Japan or Turkey.

The reason for the success is also the investment in NeuroTheryX, a Canadian company that researches the mechanisms of action and relationships behind cannabinoids such as CBD or THC and their essential oils. Synbiotic subscribed to a two-million-euro convertible note from the company, with the option to convert it into 13.33 percent of the company's shares and subsequently acquire it outright. "CBDPlus is the first, spectacular result of this collaboration," says Müller. NeuroTheryX has already investigated more than 100 plants, and more are to follow and expand the product range.